華西醫院人工智能生態發展新盟友:與一脈陽光(2522.HK)影禾醫脈簽署戰略合作協議
3月12日,中國第三方醫學影像服務領軍企業一脈陽光(2522.HK)、中國西部醫療高地四川大學華西醫院與人工智能創新先鋒影禾醫脈正式簽署戰略合作協議。為實現科研成果的高效轉化,三方將共同建設“科研轉化型影像中心”與“華西互聯網醫院線下交付影像中心”。科研轉化型影像中心作為創新技術驗證與落地的核心載體,依託衞健委頒發的執業許可資質,聚焦醫學影像人工智能產品的先行先試與商業推廣,通過標準化數據庫建設、多中心臨牀試驗及市場化運營,加速從研發到應用的閉環轉化。同時,一脈陽光將建設運營華西及領辦醫院的“影像雲平台”,整合其覆蓋全國的影像中心資源與影禾醫脈的智能基座模型技術,打造集影像數據管理、智能質控、遠程診斷及雲端協作於一體的創新服務平台,為華西醫院及領辦醫院提供高效、同質化的影像服務支持。此外,三方將推動AI質控工具、智能輔助診斷系統在基層醫院的規模化落地,通過“技術研發—場景驗證—商業推廣”的閉環生態,加速科研成果向臨牀價值與市場效益的轉化。在人工智能重塑醫療未來的浪潮中,華西醫院、一脈陽光與影禾醫脈的三方攜手,不僅標誌着醫學影像智能化邁入全新階段,更彰顯了我國醫療創新力量以科技突破推動普惠醫療的決心與擔當。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.